Dermata Therapeutics
DRMA | NASDAQ
$0.60
-$0.02 (-3.41%)
At close: Nov 16, 2026, 4:00 PM ET
$0.64
+$0.04 (+6.63%)
After-hours:
Nov 16, 2026, 5:48 PM ET
-3.41%
(1D)No price chart data available for 1D timeframe.
Rating
52.5
Fundamentals Strong
Market Sentiment Neutral
Moat None
Sector Rank #226/1021 (Top 22%)
Key Statistics
Market Data
Market Cap $2.95M
1D Range
0.57 0.64
52W Range
0.57 3.14
Valuation (TTM)
PE -0.18
PB 0.76
EV/EBITDA 0.19
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $6.00
Cash Flow
FCF Yield -306.5%
SBC Adj. FCF Yield -311.8%
SBC Impact -1.7%
Margins
Gross Margin 54.1%
Operating Margin -13082.3%
FCF Margin -12198.9%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
100.0%
Dil EPS 3Y | 5Y 119.3% |
82.3%
FCF 3Y | 5Y 1.9% |
-3.1%
Returns
ROA -143.1%
ROE -189.7%
ROIC -248.3%
Financial Health
Net Cash
$4.82M
Current Ratio 2.36
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer ski...
Sector Healthcare
Industry Biotechnology
Employees 9
IPO Date Aug 13, 2021
Website www.dermatarx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
-$0.55
Beat 0.00%
YoY:
+66.67% REV
$74K
Beat +196.00%
Next Earnings
Mar 31, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove DRMA